Summary

Dr. Shiyanbola is the Charles R. Walgreen Jr. Professor of Pharmacy in the Department of Clinical Pharmacy. Her research program advances the use of patient-centered interdisciplinary approaches to improve diabetes and related chronic disease outcomes, medication use behaviors, health literacy and health equity. Prior to UM, she was a Professor (tenured) at the UW-Madison School of Pharmacy, Associate Director at UW Collaborative Center for Health Equity and Founding Director of the STRIDE Mentored Professional Development Program at UW Institute for Clinical and Translational Research.

She has over 15 years of experience in developing and implementing tailored medication use interventions for marginalized populations. Currently, her research is focused on designing and implementing behavioral clinical trials and interventions that incorporate psychosocial and sociocultural factors towards improving medication taking behaviors, diabetes self-management, and health equity. She also studies how to improve the reach, uptake and scale-up of evidence-based diabetes management programs among historically underrepresented populations and evaluates measurement tools that advance equity for marginalized groups. Dr. Shiyanbola uses sociobehavioral and health psychology theories and concepts in her research and employs qualitative, quantitative, and mixed methods approaches in her work.

She was a NIMHD Research Institute Scholar, NHLBI/OBSSR Randomized Behavioral Trials Fellow, NIH Mixed Methods Research Training Program Scholar, and Society of Behavioral Medicine Leadership Fellow. Dr. Shiyanbola currently serves as a member of the National Academies of Science, Engineering, and Medicine Roundtable on Health Literacy, and is a committee member of the National Academies of Science, Engineering, and Medicine Review of CDC COVID-19 Vaccine Safety Research and Communications. She is current chair of the Education and Carer Development Commitee at the Society of Behavioral Medicine Health Equity SIG and co-chair of the Scholar Interest Group at the Association for Clinical and Translational Science.

Dr. Shiyanbola's work has received numerous awards and recognition at national and international scientific conferences, and she has published in academic journals including PLOS One; BMC Public Health, BMJ Open; Current Medical Research and Opinion; and Patient Education and Counseling. She is the author of over 80 publications and over 215 scientific presentations including invited talks, symposiums, and seminars.

She has been funded by the National Institute for Diabetes and Digestive and Kidney Diseases, Agency for Healthcare Research and Quality, Center for Disease Control and Prevention, NIH/KL2 Career Development Award, Community Pharmacy Foundation, MERCK Sharp & Dohme, UW Institute for Clinical and Translational Research, Baldwin Wisconsin Idea Endowment Fund, UW Center for Demography of Aging and Health, Morgridge Center for Public Service, and the UW Office of the Vice Chancellor for Research and Graduate Education. She serves on the editorial board for Research in Social and Administrative Pharmacy.

Dr. Shiyanbola received the 2023 Society of Behavioral Medicine Health Equity SIG Mentorship Award, and the 2024 UW Institute of Clinical and Translational Research Faculty Mentorship Award.

Research Interests

  • Diabetes and Related Chronic Diseases

    Medication Use Behaviors and Self-Management

    Intervention Development and Implementation

    Clinical Trials

    Mixed Methods

    Health Literacy and Research Literacy

    Health Equity for Marginalized Groups

    Patient Perspectives and Community Engagement

Selected Publications

  • Wen M-J, …. Shiyanbola OO. Peer Ambassador Perspectives in a Culturally Tailored Self-Management Intervention for African Americans with Type 2 Diabetes: A Qualitative Study. Pharmacy. 2024; 12(3):75.

    Nacht C, Jacobson N, Shiyanbola OO, et al. Parent perceptions of physician notes during hospitalization: A comparison across health literacy levels. Hospital Pediatrics e2023007240.

    Abrams L, Look K, Shiyanbola OO. A Quantitative Analysis of the Association Between Chronic Illness, Patient-Provider Communication, and Patient BMI. Health Communication. (2023) 1-8.

    Rao, D., Stevenson, B., & Shiyanbola, O. O. (2023). Using the integrated theory of health behavior change to assess factors affecting diabetes medication adherence among black adults during COVID-19: an explanatory

    sequential mixed methods design. Ethnicity & health, 1–23.

    Tarfa, ….Shiyanbola, O. (2023). A qualitative exploration of the experiences of peer leaders in an intervention to improve diabetes medication adherence in African Americans. BMC public health, 23(1), 144.

    Shiyanbola, et al. (2022). Protocol for a Pilot Randomized Controlled Mixed Methods Feasibility Trial of a Culturally Adapted Peer Support and Self-Management Intervention for African Americans. Pharmacy (Basel, Switzerland), 11(1), 2.

    Shiyanbola, et al. (2022). A feasibility pilot trial of a peer-support educational behavioral intervention to improve diabetes medication adherence in African Americans. Pilot and feasibility studies, 8(1), 240.

    Shiyanbola, et al. (2022). A Culturally Tailored Diabetes Self-Management Intervention Incorporating Race-Congruent Peer Support to Address Beliefs, Medication Adherence and Diabetes Control in African Americans: A Pilot Feasibility Study. Patient preference and adherence, 16, 2893–2912.

    Wen, M. J., … Shiyanbola, O. O. (2022). Perspectives on a Novel Culturally Tailored Diabetes Self-Management Program for African Americans: A Qualitative Study of Healthcare Professionals and Organizational Leaders. International journal of environmental research and public health, 19(19), 12814.

    Shiyanbola, et al (2022). Psychometric evaluation of a culturally adapted illness perception questionnaire for African Americans with type 2 diabetes. BMC public health, 22(1), 741.

    Bader, M., Zheng, L., Rao, D., Shiyanbola, O., et al. (2022). Towards a more patient-centered clinical trial process: A systematic review of interventions incorporating health literacy best practices. Contemporary clinical trials, 106733. https://doi.org/10.1016/j.cct.2022.106733

    Maurer, M. A., Shiyanbola, O. O., Mott, M. L., & Means, J. (2022). Engaging Patient Advisory Boards of African American Community Members with Type 2 Diabetes in Implementing and Refining a Peer-Led Medication

    Adherence Intervention. Pharmacy (Basel, Switzerland), 10(2), 37.

    Shiyanbola, et al. (2022). Feasibility of a Randomized Controlled Mixed Methods Trial to Address Health Literacy, Beliefs, Medication Adherence, and Self-Efficacy (ADHERE) in a Clinical Pharmacist-Led Clinic. Patient preference and adherence, 16, 679–696.

    Huang, Y. M., & Shiyanbola, O. O. (2021). Investigation of Barriers and Facilitators to Medication Adherence in Patients With Type 2 Diabetes Across Different Health Literacy Levels: An Explanatory Sequential Mixed Methods Study. Frontiers in pharmacology, 12, 745749.

    Shiyanbola, et al. (2021). Using an exploratory sequential mixed methods design to adapt an Illness Perception Questionnaire for African Americans with diabetes: the mixed data integration process. Health psychology and behavioral medicine, 9(1), 796–817.

    Rao, D….., Shiyanbola. (2021). Perceptions of psychosocial and interpersonal factors affecting self-management behaviors among African Americans with diabetes. Exploratory research in clinical and social pharmacy, 3, 100057. https://doi.org/10.1016/j.rcsop.2021.100057

    Rao, D., & Shiyanbola, O. (2021). Best practices for conducting and writing mixed methods research in social pharmacy. Research in social & administrative pharmacy : RSAP, S1551-7411(21)00156-X.